000 01570 a2200421 4500
005 20250513094402.0
264 0 _c19961001
008 199610s 0 0 eng d
022 _a0193-1091
024 7 _a10.1097/00000372-199604000-00014
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aArrese, J E
245 0 0 _aFatal hyalohyphomycosis following Fusarium onychomycosis in an immunocompromised patient.
_h[electronic resource]
260 _bThe American Journal of dermatopathology
_cApr 1996
300 _a196-8 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAdult
650 0 4 _aAmphotericin B
_xtherapeutic use
650 0 4 _aAntifungal Agents
_xtherapeutic use
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aBone Marrow Transplantation
650 0 4 _aFatal Outcome
650 0 4 _aFoot Dermatoses
_xdrug therapy
650 0 4 _aFungemia
_xdrug therapy
650 0 4 _aFusarium
_xisolation & purification
650 0 4 _aHumans
650 0 4 _aImmunocompromised Host
650 0 4 _aLymphoma, B-Cell
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMycoses
_xdrug therapy
650 0 4 _aNeoplasm Recurrence, Local
650 0 4 _aOnychomycosis
_xdrug therapy
650 0 4 _aPrecursor Cell Lymphoblastic Leukemia-Lymphoma
_xdrug therapy
700 1 _aPiérard-Franchimont, C
700 1 _aPiérard, G E
773 0 _tThe American Journal of dermatopathology
_gvol. 18
_gno. 2
_gp. 196-8
856 4 0 _uhttps://doi.org/10.1097/00000372-199604000-00014
_zAvailable from publisher's website
999 _c8737052
_d8737052